ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-OR059

Percentage of Glomerular Crescents Predicts Renal Outcomes in Children with IgA Vasculitis – A Midwest Pediatric Nephrology Consortium Study

Session Information

Category: Glomerular Diseases

  • 1203 Glomerular Diseases: Clinical, Outcomes, and Trials


  • Wenderfer, Scott E., Baylor College of Medicine, Houston, Texas, United States
  • Rheault, Michelle N., University of Minnesota, Minneapolis, Minnesota, United States
  • Selewski, David T., University of Michigan, Ann Arbor, Michigan, United States
  • Tran, Cheryl L., Mayo Clinic, Rochester, Minnesota, United States
  • Pan, Cynthia G., Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Seamon, Meredith, The University of Utah, Salt Lake City, Utah, United States
  • Nelson, Raoul D., The University of Utah, Salt Lake City, Utah, United States
  • Twombley, Katherine, Medical University of South Carolina, Charleston, South Carolina, United States
  • Onder, Ali Mirza, University of Tennessee, Memphis, Tennessee, United States
  • Flynn, Joseph T., Seattle Children's Hospital, Seattle, Washington, United States
  • Maliakkal, Joseph George, Saint Louis University School of Medicine, St. Louis, Missouri, United States
  • Smoyer, William E., Nationwide Children's Hospital, Columbus, Ohio, United States
  • Hidalgo, Guillermo, Eastern Carolina University, Greenville, North Carolina, United States

While crescents on kidney biopsy predict poor outcome for children with IgA vasculitis, evidence-based thresholds for %crescents most predictive of renal risk are not established. The International Study of Kidney Disease in Children (ISKDC) used 50% and 75% thresholds to grade severity of crescentic glomerulonephritis. MEST-C scoring for IgA nephropathy has also been proposed for IgA vasculitis: 1 point for any glomerular crescent and 2 when crescents involve >25% of glomeruli.


To test the validity of 25, 50, and 75% thresholds for crescents in IgA vasculitis, we identified 62 patients (13 centers) in the IRB-approved Midwest Pediatric Nephrology Consortium Glomerulonephritis with Crescents Registry (18% of total). Enrollment included patients <21 yo with >1 crescentic glomerulus on biopsy from 2004-16. Primary outcome was end stage kidney disease (ESKD) at 1 year. Secondary outcomes included estimated glomerular filtration rate (eGFR) at 1 year and change in eGFR over time. Crescents were defined by local renal pathologist.


The cohort was 47% female, 53% white, 3% black, 18% Hispanic, and 3% Asian. Median age at biopsy was 8 years (range 6-11) with 2.6 years median follow-up (IQR 1.7-4.8). A median of 36 glomeruli were sampled per biopsy (IQR 27-57). The median %crescents was 10.8 (IQR 7-18%, max 83%). Cellular crescents were seen in 95% of biopsies; fibrous crescents in 27%; both in 23%. Only 2% of children had crescents in >50% of glomeruli, and only one in >75% of glomeruli. One child with 13% cellular and 3% fibrous crescents advanced to ESKD at 26 months post-biopsy. Median change in eGFR was +2.8 mL/min/1.73m2/year (IQR -20 to +24) at 1 year and -1.5 (IQR -7 to +6) at latest follow-up. Change in eGFR was 2-fold greater for children with >25% crescents (-3.6) vs. those with <25% (-1.6).


Children with higher %crescents present with lower GFRs but most have significant recovery of eGFR at 1 year. Utility of the ISKDC thresholds for grading crescents in IgAV is limited, due to low prevalence of biopsies with crescents >50%. Long term, the 25% threshold for cellular crescents appears to predict worsening GFR decline.